{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T20:45:18Z","timestamp":1790541918095,"version":"4.1.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.vaccine.2009.04.066","type":"journal-article","created":{"date-parts":[[2009,5,24]],"date-time":"2009-05-24T04:53:32Z","timestamp":1243140812000},"page":"B117-B125","source":"Crossref","is-referenced-by-count":71,"special_numbering":"S2","title":["Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease"],"prefix":"10.1016","volume":"27","author":[{"given":"Dan M.","family":"Granoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.04.066_bib1","series-title":"Vaccines","first-page":"399","article-title":"Meningoccal vaccines","author":"Granoff","year":"2008"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.tim.2007.03.005","article-title":"Interactions between Neisseria meningitidis and the complement system","volume":"15","author":"Schneider","year":"2007","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2009.04.066_bib3","series-title":"Handbook of meningococcal disease: meningococcal disease, pathogenicity and prevention","first-page":"273","article-title":"Role of complement in defense against meningococcal infections","author":"Ram","year":"2006"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib4","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1182\/blood-2003-03-0703","article-title":"Inhibition of C5a-induced inflammation with preserved C5b-9-mediated bactericidal activity in a human whole blood model of meningococcal sepsis","volume":"102","author":"Sprong","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/156.1.107","article-title":"Bactericidal activity for Neisseria meningitidis in properdin-deficient sera","volume":"156","author":"S\u00f6derstr\u00f6m","year":"1987","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1128\/CMR.4.3.359","article-title":"Infectious diseases associated with complement deficiencies","volume":"4","author":"Figueroa","year":"1991","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF02918259","article-title":"Complement deficiency states and meningococcal disease","volume":"12","author":"Figueroa","year":"1993","journal-title":"Immunol Res"},{"issue":"8663","key":"10.1016\/j.vaccine.2009.04.066_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0140-6736(89)90712-5","article-title":"Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups","volume":"2","author":"Fijen","year":"1989","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib9","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/515075","article-title":"Assessment of complement deficiency in patients with meningococcal disease in The Netherlands","volume":"28","author":"Fijen","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/BF02276718","article-title":"Inherited complement deficiency in children surviving fulminant meningococcal septic shock","volume":"154","author":"Derkx","year":"1995","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib11","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0090-1229(92)90186-R","article-title":"Immunological evaluation of late complement component-deficient individuals","volume":"64","author":"Platonov","year":"1992","journal-title":"Clin Immunol Immunopathol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/00005792-199311000-00002","article-title":"Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R.","volume":"72","author":"Platonov","year":"1993","journal-title":"Medicine (Baltimore)"},{"issue":"27\u201330","key":"10.1016\/j.vaccine.2009.04.066_bib13","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1016\/S0264-410X(03)00440-7","article-title":"Long term effects of vaccination of patients deficient in a late complement component with a tetravalent meningococcal polysaccharide vaccine","volume":"21","author":"Platonov","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.04.066_bib14","doi-asserted-by":"crossref","unstructured":"Plested J, Welsch JA, Granoff DM. An ex-vivo meningococcal human blood bacteremia model for measuring vaccine-induced serum passive protective activity. Clin Vaccine Immunol 2009 [Epub ahead of print].","DOI":"10.1128\/CVI.00007-09"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib15","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/CVI.00036-08","article-title":"Vaccine-induced opsonophagocytic immunity to Neisseria meningitidis group B","volume":"15","author":"Plested","year":"2008","journal-title":"Clin Vaccine Immunol"},{"issue":"17\u201318","key":"10.1016\/j.vaccine.2009.04.066_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.vaccine.2005.01.051","article-title":"Meningococcal surrogates of protection\u2014serum bactericidal antibody activity","volume":"23","author":"Borrow","year":"2005","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1586\/14760584.3.1.77","article-title":"Serologic correlates of protection for evaluating the response to meningococcal vaccines","volume":"3","author":"Balmer","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from post-licensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.04.066_bib19","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1086\/379375","article-title":"Antibody to genome-derived neisserial antigen 2132, a Neisseria meningitidis candidate vaccine, confers protection against bacteremia in the absence of complement-mediated bactericidal activity","volume":"188","author":"Welsch","year":"2003","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib20","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.066_bib22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1128\/CVI.00102-07","article-title":"Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in England","volume":"14","author":"Trotter","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1099\/0022-1317-51-9-717","article-title":"Impact of meningococcal C conjugate vaccine in the UK","volume":"51","author":"Balmer","year":"2002","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib24","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1086\/315158","article-title":"The changing epidemiology of meningococcal disease in the United States, 1992\u20131996","volume":"180","author":"Rosenstein","year":"1999","journal-title":"J Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2009.04.066_bib25","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","article-title":"Meningococcal disease","volume":"344","author":"Rosenstein","year":"2001","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib26","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1046\/j.1365-3083.2003.01326.x","article-title":"Ontogeny of complement regulatory proteins\u2014concentrations of factor h, factor I, c4b-binding protein, properdin and vitronectin in healthy children of different ages and in adults","volume":"58","author":"de Paula","year":"2003","journal-title":"Scand J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1651-2227.1999.tb00988.x","article-title":"Complement haemolytic activity (classical and alternative pathways), C3,C4 and factor B titres in healthy children","volume":"88","author":"Ferriani","year":"1999","journal-title":"Acta Paediatr"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.066_bib28","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1128\/CVI.00341-07","article-title":"Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal activity","volume":"14","author":"Welsch","year":"2007","journal-title":"Clin Vaccine Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib29","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"issue":"9320","key":"10.1016\/j.vaccine.2009.04.066_bib30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(02)08679-8","article-title":"Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination","volume":"359","author":"Maiden","year":"2002","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib31","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3201\/eid1206.051297","article-title":"Social behavior and meningococcal carriage in British teenagers","volume":"12","author":"MacLennan","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.066_bib32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/infdis\/173.4.1009","article-title":"Analysis of meningococcal serogroup C-specific antibody levels in British Columbian children and adolescents","volume":"173","author":"Mitchell","year":"1996","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib33","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/315352","article-title":"Lack of immunity in university students before an outbreak of serogroup C meningococcal infection","volume":"181","author":"Jones","year":"2000","journal-title":"J Infect Dis"},{"issue":"34","key":"10.1016\/j.vaccine.2009.04.066_bib34","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1016\/j.vaccine.2005.03.031","article-title":"Immunogenicity of an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine in 2-year old children","volume":"23","author":"Granoff","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.066_bib35","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.vaccine.2004.07.042","article-title":"Naturally-acquired immunity to Neisseria meningitidis group A","volume":"23","author":"Amir","year":"2005","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib36","doi-asserted-by":"crossref","first-page":"5903","DOI":"10.1128\/IAI.72.10.5903-5909.2004","article-title":"Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity","volume":"72","author":"Welsch","year":"2004","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib37","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1128\/IAI.40.1.257-264.1983","article-title":"Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide","volume":"40","author":"Zollinger","year":"1983","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib38","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1128\/CDLI.8.3.616-623.2001","article-title":"Importance of complement source in measuring meningococcal bactericidal titers","volume":"8","author":"Santos","year":"2001","journal-title":"Clin Diagn Lab Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib39","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib40","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/biol.2000.0253","article-title":"Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines","volume":"28","author":"Jodar","year":"2000","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib41","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib42","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1001\/archpedi.159.10.907","article-title":"Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents","volume":"159","author":"Keyserling","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.066_bib43","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib44","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib45","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/IAI.01071-08","article-title":"Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37","volume":"77","author":"Seib","year":"2009","journal-title":"Infect Immun"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.066_bib46","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/528994","article-title":"Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen","volume":"197","author":"Welsch","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib47","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1128\/IAI.01191-08","article-title":"Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera","volume":"77","author":"Granoff","year":"2009","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.066_bib48","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.066_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1006\/mpat.1999.0296","article-title":"Assessment of immune response to meningococcal disease: comparison of a whole-blood assay and the serum bactericidal assay","volume":"27","author":"Ison","year":"1999","journal-title":"Microb Pathog"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib50","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1097\/01.inf.0000091283.10199.dc","article-title":"Age dependence of in vitro survival of meningococci in whole blood during childhood","volume":"22","author":"Ison","year":"2003","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0882-4010(95)90093-4","article-title":"Whole blood model of meningococcal bacteraemia\u2014a method for exploring host\u2013bacterial interactions","volume":"18","author":"Ison","year":"1995","journal-title":"Microb Pathog"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1006\/mpat.2000.0419","article-title":"Murine, monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model","volume":"30","author":"Toropainen","year":"2001","journal-title":"Microb Pathog"},{"issue":"20\u201321","key":"10.1016\/j.vaccine.2009.04.066_bib53","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1016\/S0264-410X(99)00049-3","article-title":"The infant rat model adapted to evaluate human sera for protective immunity to group B meningococci","volume":"17","author":"Toropainen","year":"1999","journal-title":"Vaccine"},{"issue":"40","key":"10.1016\/j.vaccine.2009.04.066_bib54","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1016\/j.vaccine.2005.05.005","article-title":"Passive protection in the infant rat protection assay by sera taken before and after vaccination of teenagers with serogroup B meningococcal outer membrane vesicle vaccines","volume":"23","author":"Toropainen","year":"2005","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2009.04.066_bib55","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1128\/IAI.73.8.4694-4703.2005","article-title":"Protection by natural human immunoglobulin M antibody to meningococcal serogroup B capsular polysaccharide in the infant rat protection assay is independent of complement-mediated bacterial lysis","volume":"73","author":"Toropainen","year":"2005","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib56","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1128\/IAI.74.5.2803-2808.2006","article-title":"Protection by meningococcal outer membrane protein PorA-specific antibodies and a serogroup B capsular polysaccharide-specific antibody in complement-sufficient and C6-deficient infant rats","volume":"74","author":"Toropainen","year":"2006","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib57","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.4049\/jimmunol.172.9.5606","article-title":"Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine","volume":"172","author":"Welsch","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib58","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000151035.64356.f8","article-title":"Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"24","author":"Granoff","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.066_bib59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1086\/432102","article-title":"Protective antibody responses elicited by a meningococcal outer membrane vesicle vaccine with overexpressed genome-derived neisserial antigen 1870","volume":"192","author":"Hou","year":"2005","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib60","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1086\/500512","article-title":"Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine","volume":"193","author":"Vu","year":"2006","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib61","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1093\/infdis\/168.1.227","article-title":"Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement component-deficient individuals","volume":"168","author":"Andreoni","year":"1993","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.066_bib62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/00005373-199510000-00035","article-title":"Lethal Waterhouse\u2013Friderichsen syndrome in posttraumatic asplenia","volume":"39","author":"Locker","year":"1995","journal-title":"J Trauma"},{"issue":"12","key":"10.1016\/j.vaccine.2009.04.066_bib63","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1046\/j.1198-743x.2001.00355.x","article-title":"Prevention and management of infections in patients without a spleen","volume":"7","author":"Davidson","year":"2001","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1034\/j.1600-0609.2003.00158.x","article-title":"Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes","volume":"71","author":"Castagnola","year":"2003","journal-title":"Eur J Haematol"},{"issue":"RR-7","key":"10.1016\/j.vaccine.2009.04.066_bib65","first-page":"1","article-title":"Centers for Disease Control and Prevention. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"54","author":"Bilukha","year":"2005","journal-title":"MMWR Recomm Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib66","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1128\/JCM.32.9.2185-2191.1994","article-title":"Characterization of strains of Neisseria meningitidis recovered from complement-sufficient and complement-deficient patients in the Western Cape Province, South Africa","volume":"32","author":"Orren","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib67","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1093\/clinids\/18.5.780","article-title":"Complement deficiency predisposes for meningitis due to nongroupable meningococci and Neisseria-related bacteria","volume":"18","author":"Fijen","year":"1994","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib68","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1093\/infdis\/155.6.1266","article-title":"Killing of Neisseria meningitidis by human neutrophils: implications for normal and complement-deficient individuals","volume":"155","author":"Ross","year":"1987","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2009.04.066_bib69","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000070219","article-title":"Antibody-dependent killing of meningococci by human neutrophils in serum of late complement component-deficient patients","volume":"130","author":"Platonov","year":"2003","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.04.066_bib70","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.1365-2249.1998.00738.x","article-title":"Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine","volume":"114","author":"Fijen","year":"1998","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib71","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1128\/IAI.00033-08","article-title":"Bactericidal antibody responses induced by meningococcal recombinant chimeric factor H-binding protein vaccines","volume":"76","author":"Beernink","year":"2008","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib72","doi-asserted-by":"crossref","first-page":"4232","DOI":"10.1128\/IAI.00367-08","article-title":"Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate, factor H-binding protein","volume":"76","author":"Beernink","year":"2008","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.04.066_bib73","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.inf.0000129686.12470.e6","article-title":"Protective activity of group C anticapsular antibodies elicited in two-year-olds by an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine","volume":"23","author":"Granoff","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2009.04.066_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1128\/IAI.71.1.275-286.2003","article-title":"Age-related disparity in functional activities of human group C serum anticapsular antibodies elicited by meningococcal polysaccharide vaccine","volume":"71","author":"Harris","year":"2003","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib75","first-page":"195","article-title":"Vaccine against group B Neisseria meningitidis: protection trial and mass vaccination results in Cuba","volume":"14","author":"Sierra","year":"1991","journal-title":"NIPH Ann"},{"issue":"8827","key":"10.1016\/j.vaccine.2009.04.066_bib76","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.vaccine.2009.04.066_bib77","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1128\/IAI.62.10.4419-4424.1994","article-title":"Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy","volume":"62","author":"Milagres","year":"1994","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.04.066_bib78","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/24.5.1050","article-title":"Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study","volume":"24","author":"Noronha","year":"1995","journal-title":"Int J Epidemiol"},{"issue":"9","key":"10.1016\/j.vaccine.2009.04.066_bib79","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/0264-410X(94)00037-N","article-title":"Efficacy, safety, and immunogenicity of a meningococcal group B (15:P1.3) outer membrane protein vaccine in Iquique, Chile. Chilean National Committee for Meningococcal Disease","volume":"13","author":"Boslego","year":"1995","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib80","first-page":"125","article-title":"Results of an efficacy trial with an outer membrane vesicle vaccine against systemic serogroup B meningococcal disease in Norway","volume":"14","author":"Bjune","year":"1991","journal-title":"NIPH Ann"},{"issue":"8775","key":"10.1016\/j.vaccine.2009.04.066_bib81","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/0140-6736(91)91961-S","article-title":"Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway","volume":"338","author":"Bjune","year":"1991","journal-title":"Lancet"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2009.04.066_bib82","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2009.04.066_bib83","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.04.066_bib84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/ije\/dyn228","article-title":"Use of an observational cohort study to estimate the effectiveness of the New Zealand group B meningococcal vaccine in children aged under 5 years","volume":"38","author":"Galloway","year":"2009","journal-title":"Int J Epidemiol"},{"issue":"16","key":"10.1016\/j.vaccine.2009.04.066_bib85","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1016\/j.vaccine.2007.01.023","article-title":"Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand","volume":"25","author":"Oster","year":"2007","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09006203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T13:50:49Z","timestamp":1589809849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09006203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":85,"alternative-id":["S0264410X09006203"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.04.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}